Paper · 26314253
The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production.
Litwin M and 6 others. Mol Cell Biochem, 2015. Cited by 25 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production. Papers, record 26314253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26314253
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiogenic Proteins | Major topic |
| Cell Movement | Major topic |
| Endothelial Progenitor Cells | Major topic |
| Fibroblast Growth Factor 2 | Major topic |
| Neovascularization, Physiologic | Major topic |
| Cell Line | |
| Cell Proliferation | |
| Chemokine CCL8 | |
| Hepatocyte Growth Factor | |
| Humans | |
| Interleukins | |
| Signal Transduction | |
| Time Factors | |
| Transfection | |
| Up-Regulation | |
| Vascular Endothelial Growth Factor A |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,553,709 | Understanding the biology of angiogenesis: review of the most important molecular mechanisms. | Blood Cells Mol Dis | 2007 | https://conductscience.org/library/papers/17553709 | PubMed |
| 2 | 2,359,136 | New colorimetric cytotoxicity assay for anticancer-drug screening. | J Natl Cancer Inst | 1990 | https://conductscience.org/library/papers/2359136 | PubMed |
| 3 | 5,432,063 | Cleavage of structural proteins during the assembly of the head of bacteriophage T4. | Nature | 1970 | https://conductscience.org/library/papers/5432063 | PubMed |
| 4 | 8,246,443 | Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. | Lab Invest | 1993 | https://conductscience.org/library/papers/8246443 | PubMed |
| 5 | 12,433,837 | Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs. | Circ Res | 2002 | https://conductscience.org/library/papers/12433837 | PubMed |
| 6 | 21,953,501 | Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21953501 | PubMed |
| 7 | 18,591,450 | Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. | Circulation | 2008 | https://conductscience.org/library/papers/18591450 | PubMed |
| 8 | 21,710,642 | CD133 positive progenitor endothelial cell lines from human cord blood. | Cytometry A | 2011 | https://conductscience.org/library/papers/21710642 | PubMed |
| 9 | 12,086,757 | Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. | Lancet | 2002 | https://conductscience.org/library/papers/12086757 | PubMed |
| 10 | 11,948,428 | Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. | Oncogene | 2002 | https://conductscience.org/library/papers/11948428 | PubMed |
1 to 10 of 50
See all 50 referencesCited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,204,283 | Methionine induced placental angiogenesis through activating WNT3A/CTNNB1-PIGF-VEGFR1 pathway. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/41204283 | PubMed |
| 40,225,569 | Deciphering single-cell landscape unravels cell-type-specific functional roles of RNA m6A modification in atherosclerosis. | Theranostics | 2025 | https://conductscience.org/library/papers/40225569 | PubMed |
| 39,827,700 | Leveraging the predictive power of a 3D in vitro vascularization screening assay for hydrogel-based tissue-engineered periosteum allograft healing. | Biomater Adv | 2025 | https://conductscience.org/library/papers/39827700 | PubMed |
| 38,017,409 | Identification and characterization of ARID1A-interacting proteins in renal tubular cells and their molecular regulation of angiogenesis. | J Transl Med | 2023 | https://conductscience.org/library/papers/38017409 | PubMed |
| 37,185,814 | Epigenetic landscape reveals MECOM as an endothelial lineage regulator. | Nat Commun | 2023 | https://conductscience.org/library/papers/37185814 | PubMed |
| 35,789,679 | Endothelial Dysfunction in the Context of Blood-Brain Barrier Modeling. | J Evol Biochem Physiol | 2022 | https://conductscience.org/library/papers/35789679 | PubMed |
| 34,805,825 | Exogenous FGF-2 improves biological activity of endothelial progenitor cells exposed to high glucose conditions. | J Interv Med | 2018 | https://conductscience.org/library/papers/34805825 | PubMed |
| 34,067,330 | Healing and Angiogenic Properties of Collagen/Chitosan Scaffolds Enriched with Hyperstable FGF2-STAB® Protein: In Vitro, Ex Ovo and In Vivo Comprehensive Evaluation. | Biomedicines | 2021 | https://conductscience.org/library/papers/34067330 | PubMed |
| 33,126,651 | Co-Culture of Primary Human Coronary Artery and Internal Thoracic Artery Endothelial Cells Results in Mutually Beneficial Paracrine Interactions. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33126651 | PubMed |
| 32,733,433 | Interaction of Microglia and Astrocytes in the Neurovascular Unit. | Front Immunol | 2020 | https://conductscience.org/library/papers/32733433 | PubMed |
1 to 10 of 15
See all 15 cited byGenes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL8 | 6,355 | PubTator's text mining | https://conductscience.org/library/genes/6355 | NCBI Gene |
| FGF2 | 2,247 | PubTator's text mining | https://conductscience.org/library/genes/2247 | NCBI Gene |
| HGF | 3,082 | PubTator's text mining | https://conductscience.org/library/genes/3082 | NCBI Gene |
| VEGFA | 7,422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26314253
GET https://conductscience.org/api/papers/v1/26314253/references?page=2